Authors/Disclosures
|
Peter Novak, MD
(Brigham and Women'S Faulkner, Neurology)
|
Dr. Novak has received personal compensation for serving as an employee of Dysimmune Disease Foundation. Dr. Novak has stock in Pfeizer. Dr. Novak has stock in Moderna. Dr. Novak has stock in Novavax. Dr. Novak has stock in Editas Medicine. Dr. Novak has stock in Prothena. Dr. Novak has received publishing royalties from a publication relating to health care. |
|
Paula D. Ravin, MD
(UCLA)
|
No disclosure on file |
|
Lan Qin, MD, PhD, FAAN
(Dept of Neuro Univ of Massachussetts)
|
No disclosure on file |
|
J M. Girard, MD
|
Dr. Girard has nothing to disclose. |
|
James B. Leverenz, MD, FAAN
(Cleveland Clinic)
|
Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. |